China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
23.21
0.00 (0.00%)
Nov 6, 2026, 3:00 PM CST
SHA:600750 Revenue
China Resources Jiangzhong Pharmaceutical Co.,Ltd had revenue of 729.62M CNY in the quarter ending September 30, 2026, a decrease of -7.88%. This brings the company's total for the last twelve months to 3.95B, down -6.86% year-over-year. In the year 2025, China Resources Jiangzhong Pharmaceutical Co.,Ltd had annual revenue of 4.22B, down -4.87%. That makes China Resources Jiangzhong Pharmaceutical Co.,Ltd the 10,337th largest company in the world by revenue and 1,683rd in China.
Revenue (ttm)
3.95B
Revenue Growth
-6.86%
P/S Ratio
3.70
Revenue / Employee
907.22K
Employees
4,352
Market Cap
14.61B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full SHA:600750 breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.22B | -215.95M | -4.87% |
| Dec 31, 2024 | 4.44B | -117.76M | -2.59% |
| Dec 31, 2023 | 4.55B | 668.03M | 17.19% |
| Dec 31, 2022 | 3.89B | 1.01B | 35.19% |
| Dec 31, 2021 | 2.87B | 432.52M | 17.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.